title: Monitoring patients with ankylosing spondylitis on anti-TNF monotherapy: too much too often?
authors.affiliation: a Department of Rheumatology , Peterborough and Stamford Hospitals NHS Foundation Trust , Peterborough , UK.
authors.forename: W
authors.initials: W
authors.lastname: Gunasekera
authors.affiliation: b Department of Rheumatology , North Bristol NHS Trust , Bristol , UK.
authors.forename: P
authors.initials: P
authors.lastname: Creamer
authors.affiliation: c University of Oxford , Oxford , UK.
authors.forename: K
authors.initials: K
authors.lastname: Creamer
authors.affiliation: d Royal National Hospital for Rheumatic Diseases , NHS Foundation Trust , Bath , UK.
authors.forename: R
authors.initials: R
authors.lastname: Sengupta
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001772:Blood Cell Count / Q000379:methods; D017281:Cost of Illness; D016903:Drug Monitoring / Q000191:economics / Q000379:methods; D006801:Humans; D007677:Kidney Function Tests / Q000379:methods; D008111:Liver Function Tests / Q000379:methods; D020380:Needs Assessment; D013167:Spondylitis, Ankylosing / Q000175:diagnosis / Q000188:drug therapy / Q000191:economics; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D006113:United Kingdom
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha